Ipscs: A preclinical drug research tool for neurological disorders

Autor: Giuseppe Antonino Attaguile, Giuseppina Cantarella, Brigida Sabrina Pistone, Sebastiano Cavallaro, Valentina La Cognata, Velia D'Agata, Gabriele Bonaventura, Rosario Iemmolo, Maria Luisa Barcellona, Giuseppe Raudino

Publikováno v: International journal of molecular sciences
22 (2021). doi:10.3390/ijms22094596
info:cnr-pdr/source/autori:Gabriele Bonaventura; Rosario Iemmolo; Giuseppe Antonino Attaguile; Valentina La Cognata; Brigida Sabrina Pistone; Giuseppe Raudino; Velia D'agata; Giuseppina Cantarella; Maria Luisa Barcellona; Sebastiano Cavallaro;/titolo:Ipscs: A preclinical drug research tool for neurological disorders/doi:10.3390%2Fijms22094596/rivista:International journal of molecular sciences (Print)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:22
International Journal of Molecular Sciences, Vol 22, Iss 4596, p 4596 (2021)
International Journal of Molecular Sciences

The development and commercialization of new drugs is an articulated, lengthy, and very expensive process that proceeds through several steps, starting from target identification, screening new leading compounds for testing in preclinical studies, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffa01137acbe08ea73dd88aca4772d9
http://www.scopus.com/record/display.url?eid=2-s2.0-85104710536&origin=inward